StockData
Tvardi Therapeutics, Inc. logo

Tvardi Therapeutics, Inc. (TVRD) stock

TVRDNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 13, 2026Score 6/30
$1.04+0.03 (+2.97%)

Close on Nov 18, 2026Market cap $13.87MP/E –Yield 0.00%

Tvardi Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Tvardi Therapeutics's market cap was $12.57M on Nov 11, 2026, against $38.64M a year earlier. Over the last 5 years it ranged from $7.44M to $1.95B, with a median of $121.42M.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$12.57M-68.8%
2025Dec 31, 2025$40.33M-51.9%
2024Dec 31, 2024$83.92M-30.9%
2023Dec 29, 2023$121.42M-93.0%
2022Dec 30, 2022$1.73B-5.6%
2021Dec 31, 2021$1.83B-13.9%
2020Dec 31, 2020$2.13B-5.6%
2019Dec 31, 2019$2.26B+46.8%
2018Dec 31, 2018$1.54B+28.3%
2017Dec 29, 2017$1.20B+57.5%
2016Dec 30, 2016$760.41M-44.8%
2015Dec 31, 2015$1.38B+102.2%
2014Dec 31, 2014$681.31M–

More Tvardi Therapeutics figures

See a number that looks wrong?